Trigger point evaluation in migraine patients:: an indication of peripheral sensitization linked to migraine predisposition?

被引:95
作者
Calandre, EP [1 ]
Hidalgo, J [1 ]
García-Leiva, JM [1 ]
Rico-Villademoros, F [1 ]
机构
[1] Univ Granada, Inst Neurosci, E-18012 Granada, Spain
关键词
central sensitization; migraine; peripheral sensitization; referred pain; trigger points;
D O I
10.1111/j.1468-1331.2006.01181.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although migraine is a neurovascular disorder, both scalp tenderness and referred pain have been observed in migraine patients. The present study was carried out to investigate the presence of trigger points eliciting referred pain in 98 migraine patients and in 32 healthy subjects. Trigger points were found in 92 (93.9%) migraineurs and in nine (29%) controls (P < 0.0001). The number of individual migraine trigger points varied from zero to 14 (modal number: 4), and was found to be related to both the frequency of migraine attacks (P < 0.0001), and the duration of the disease (P = 0.017). About 74% of the total detected trigger points were found in temporal and/or suboccipital areas; other locations were mainly found in patients showing more than four trigger points. Trigger point palpation provoked a migraine attack in 30 (30.6%) patients. Pericraneal allodynia was found in 15 (15.3%) patients. These data indicate that nociceptive peripheral sensitization is a usual finding in migraine, and that central sensitization can develop in patients with frequent attacks and long-lasting disease. Trigger points' detection in migraine patients could be useful when applying therapies like acupuncture, needling or botulinum toxin injections directed to reduce peripheral sensitization.
引用
收藏
页码:244 / 249
页数:6
相关论文
共 25 条
[1]   Muscle tenderness in pericranial and neck-shoulder region in children with headache.: A controlled study [J].
Anttila, P ;
Metsähonkala, L ;
Mikkelsson, M ;
Aromaa, M ;
Kautiainen, H ;
Salminen, J ;
Viander, S ;
Jäppilä, E ;
Sillanpää, M .
CEPHALALGIA, 2002, 22 (05) :340-344
[2]  
Aoki KR, 2003, HEADACHE, V43, pS9
[3]   Botulinum toxin and other new approaches to migraine therapy [J].
Ashkenazi, A ;
Silberstein, SD .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :505-518
[4]   Trigger points and tender points - One and the same? Does injection treatment help? [J].
BorgStein, J ;
Stein, J .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1996, 22 (02) :305-&
[5]  
Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO
[6]  
2-N
[7]  
Calandre EP, 2003, CEPHALALGIA, V23, P713
[8]  
Dodick DW, 2003, HEADACHE, V43, pS25
[9]   Regional myofascial pain syndrome and headache: Principles of diagnosis and management [J].
Graff-Radford S.B. .
Current Pain and Headache Reports, 2001, 5 (4) :376-381
[10]   ACUPUNCTURE VERSUS METOPROLOL IN MIGRAINE PROPHYLAXIS - A RANDOMIZED TRIAL OF TRIGGER POINT INACTIVATION [J].
HESSE, J ;
MOGELVANG, B ;
SIMONSEN, H .
JOURNAL OF INTERNAL MEDICINE, 1994, 235 (05) :451-456